IP Library Granted Patent US 7,304,094
Granted Patent B2
US 7,304,094 · App. 11/261,365 · Granted Dec 4, 2007

Cyclohexyl sulphones

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,304,094
App. No.
11/261,365
Granted
Dec 4, 2007
Kind
B2
Abstract

Novel sulphones of formula I are disclosed: The compounds modulate the processing of amyloid precursor protein by gamma-secretase, and hence are useful in the treatment or prevention of Alzheimer's disease.

Claims (19)

1. A compound of formula I:

wherein:

m is 0 or 1;

Z represents CON(R 2a ) 2 ;

R 1b represents H, C 1-4 alkyl or OH;

R 1c represents H or C 1-4 alkyl;

with the proviso that when m is 1, R 1b and R 1c do not both represent C 1-4 alkyl;

Ar 1 represents C 6-10 aryl which bears 0-3 substituents independently selected from halogen, CF 3 , OH, OCF 3 , C 1-4 alkoxy or C 1-4 alkyl which optionally bears a substituent selected from halogen, CF 3 , OH and C 1-4 alkoxy;

Ar 2 represents C 6-10 aryl which bears 0-3 substituents independently selected from halogen, CF 3 , OH, OCF 3 , C 1-4 alkoxy or C 1-4 alkyl which optionally bears a substituent selected from halogen, CF 3 , OH and C 1-4 alkoxy;

R 2a represents H, C 1-6 alkyl, or C 2-6 alkenyl, wherein said alkyl or alkenyl optionally bears a substituent selected from halogen, CF 3 , or OR 2b ;

R 2b represents H, C 1-6 alkyl, or C 2-6 alkenyl, wherein said alkyl or alkenyl optionally bears a substituent selected from halogen, CF 3 , OH, or C 1-4 alkoxy;

or a pharmaceutically acceptable salt thereof.

2. A compound according to claim 1 wherein Ar 1 is selected from phenyl groups substituted in the 4-position with halogen, methyl or trifluoromethyl, and phenyl groups substituted in the 3- and 4-positions by halogen.

3. A compound according to claim 1 wherein Ar 2 is selected from phenyl groups substituted in the 2- and 5-positions by halogen.

4. A compound according to claim 1 wherein m is 0, Ar 1 represents 4-chlorophenyl, Ar 2 represents 2,5-difluorophenyl, R 1c represents H and Z represents CONH 2 .

5. A compound according to claim 1 wherein m is 0, Ar 1 represents 4-trifluoromethylphenyl, Ar 2 represents 2,5-difluorophenyl, R 1c represents H and Z represents CONH 2 .

6. A compound according to claim 1 wherein m is 0, Ar 1 represents 4-chlorophenyl, Ar 2 represents 2,5-difluorophenyl, R 1c represents H and Z represents CONHCH 2 CH 3 .

7. A pharmaceutical composition comprising a compound of formula I as defined in claim 1 , or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

8. A method of treatment of Alzheimer's disease which comprises administering to a subject suffering from Alzheimer's disease an effective amount of a compound of formula I as defined in claim 1 or a pharmaceutically acceptable salt thereof.

Assignments (2)
CHANGE OF ADDRESS Recorded May 10, 2022
From: MERCK SHARP & DOHME (UK) LIMITED
To: MERCK SHARP & DOHME (UK) LIMITED
Reel/Frame 060110/0121 →
NUNC PRO TUNC ASSIGNMENT Recorded Aug 5, 2021
From: MERCK SHARP & DOHME LIMITED
To: MERCK SHARP & DOHME (UK) LIMITED
Reel/Frame 057089/0263 →